These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11844717)

  • 21. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lupus anticoagulant induced by the combination of valproate and lamotrigine.
    Echaniz-Laguna A; Thiriaux A; Ruolt-Olivesi I; Marescaux C; Hirsch E
    Epilepsia; 1999 Nov; 40(11):1661-3. PubMed ID: 10565597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An older drug for childhood absence epilepsy.
    Potera C
    Am J Nurs; 2010 Jun; 110(6):16. PubMed ID: 20505447
    [No Abstract]   [Full Text] [Related]  

  • 24. Pretreatment behavior and subsequent medication effects in childhood absence epilepsy.
    Shinnar RC; Shinnar S; Cnaan A; Clark P; Dlugos D; Hirtz DG; Hu F; Liu C; Masur D; Weiss EF; Glauser TA;
    Neurology; 2017 Oct; 89(16):1698-1706. PubMed ID: 28916534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delirium from valproic acid with lamotrigine.
    Mueller TH; Beeber AR
    Am J Psychiatry; 2004 Jun; 161(6):1128-9. PubMed ID: 15169707
    [No Abstract]   [Full Text] [Related]  

  • 26. Suspected lamotrigine-induced toxic epidermal necrolysis.
    Söğüt A; Yilmaz A; Kilinç M; Söğüt AG; Demiralay E; Uzar H
    Acta Neurol Belg; 2003 Jun; 103(2):95-8. PubMed ID: 12892003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversible lamotrigine-induced neurobehavioral disturbances in children with epilepsy.
    Cardenas JF; Rho JM; Ng YT
    J Child Neurol; 2010 Feb; 25(2):182-7. PubMed ID: 19494356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study.
    Morris GL; Hammer AE; Kustra RP; Messenheimer JA
    Epilepsy Behav; 2004 Aug; 5(4):509-12. PubMed ID: 15256187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exacerbation of juvenile myoclonic epilepsy with lamotrigine.
    Biraben A; Allain H; Scarabin JM; Schück S; Edan G
    Neurology; 2000 Dec; 55(11):1758. PubMed ID: 11113246
    [No Abstract]   [Full Text] [Related]  

  • 30. EEG and seizure exacerbation induced by carbamazepine in Panayiotopoulos syndrome.
    Kikumoto K; Yoshinaga H; Oka M; Ito M; Endoh F; Akiyama T; Ohtsuka Y
    Epileptic Disord; 2006 Mar; 8(1):53-6. PubMed ID: 16567326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Atypical benign partial epilepsy of childhood. Clinical follow-up EEG study of 3 patients].
    Rodríguez-Barrionuevo AC; Bauzano-Poley E; Delgado-Marqués MP; Mora-Ramírez MD; Tosina-García E
    Rev Neurol; 1998 Feb; 26(150):197-204. PubMed ID: 9563088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine.
    Posner EB; Mohamed K; Marson AG
    Seizure; 2005 Mar; 14(2):117-22. PubMed ID: 15694565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lamotrigine-associated anticonvulsant hypersensitivity syndrome in bipolar disorder.
    Chang CC; Shiah IS; Yeh CB; Wang TS; Chang HA
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):741-4. PubMed ID: 16442685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of a new antiepileptic drug or an old one as first drug for treatment of absence epilepsy.
    Penovich PE; Willmore LJ
    Epilepsia; 2009 Sep; 50 Suppl 8():37-41. PubMed ID: 19702732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pityriasis rosea-like eruption associated with lamotrigine.
    Papadavid E; Panayiotides I; Makris M; Giatrakou S; Dalamaga M; Stavrianeas N; Rigopoulos D
    J Am Acad Dermatol; 2013 Jun; 68(6):e180-1. PubMed ID: 23680210
    [No Abstract]   [Full Text] [Related]  

  • 36. Leucopenia and thrombocytopenia possibly associated with lamotrigine use in a patient.
    Ural AU; Avcu F; Gokcil Z; Nevruz O; Cetin T
    Epileptic Disord; 2005 Mar; 7(1):33-5. PubMed ID: 15741138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eye movement desensitization and reprocessing in the treatment of posttraumatic stress disorder in a patient with comorbid epilepsy.
    Schneider G; Nabavi D; Heuft G
    Epilepsy Behav; 2005 Dec; 7(4):715-8. PubMed ID: 16246634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of lamotrigine on cognition in children with epilepsy.
    Pressler RM; Binnie CD; Coleshill SG; Chorley GA; Robinson RO
    Neurology; 2006 May; 66(10):1495-9. PubMed ID: 16717207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory linear verrucous epidermal nevus and epilepsy: remission during valproic acid therapy.
    Diluvio L; Campione E; Mordenti C; Bagnolo V; Cerminara C; Chimenti S; Bianchi L
    J Drugs Dermatol; 2013 Jan; 12(1):18-9. PubMed ID: 23377323
    [No Abstract]   [Full Text] [Related]  

  • 40. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Moeller JJ; Rahey SR; Sadler RM
    Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.